Archived articles

Psychedelics

Psychedelics
Psilocybin treatment for major depression effective for up to a year for most patients, study shows
Published Feb 16, 2022
Patients receiving combined treatment of psilocybin and psychotherapy report experiencing longterm benefits of decreased depressive symptoms
Psychedelics
Hopkins gets first NIH grant in 50 years for psychedelic treatment research
Published Oct 20, 2021
The nearly $4 million NIH grant will fund a multisite study of the effects of "magic mushrooms" and talk therapy on quitting smoking
Psychedelics
Breathwork to treat PTSD
Published Fall 2021
An upcoming, first-of-its kind study hopes to prove that Holotropic Breathwork therapy can treat PTSD in veterans / Johns Hopkins Magazine
Q+A
The path forward for legal medical mushrooms
Published Dec 2, 2020
Johns Hopkins researcher Matthew Johnson discusses the future for psychedelics research in light of Oregon's measure to legalize psilocybin for clinical use
Psychedelics
Inside a psilocybin playlist
Published Nov 11, 2020
Researchers rely on this carefully selected classical and contemporary music playlist to enhance the psychedelic experience for their patients during psilocybin studies
Depression
Psychedelic treatment with psilocybin shown to relieve major depression
Published Nov 11, 2020
The antidepressant effect of the psilocybin—the active compound in so-called magic mushrooms—was about four times greater than is typically seen in traditional antidepressants currently on the market
Psychedelics
A spiritual experience
Published Fall 2020
Johns Hopkins researchers discover that people who had previously identified as atheists described encountering a "benevolent entity" upon inhaling the psychedelic DMT / Johns Hopkins Magazine
Hopkins in the news
'60 Minutes' explores Hopkins' psychedelics research
Published Oct 14, 2019
Scientists Roland Griffiths and Matthew Johnson sit down with journalist Anderson Cooper to discuss the promise of psychedelics / 60 Minutes
Psychedelics
Johns Hopkins launches center for psychedelic research
Published Sept 4, 2019
The center, believed to be the first and largest of its kind, will use psychedelics to study the mind, identify therapies for diseases such as addiction, PTSD, Alzheimer's
Pharmacology
Toad venom therapy
Published Summer 2019
Psychoactive mushrooms may help individuals with depression and anxiety, but each trip can last from four to six hours. Enter the toad. / Johns Hopkins Magazine